|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07D 405/12 | |
| C07D 239/48 | |||
| C07D 405/14 | |||
| C07D 413/14 | |||
| C07D 417/14 | |||
| C07D 403/12 | |||
| A61K 31/506 |
| (11) | Patento numeris | 1664035 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04786952.4 |
| Europos patento paraiškos padavimo data | 2004-09-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-06-07 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-02-16 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2004/010348 |
| Data | 2004-09-15 |
| (87) | Numeris | WO 2005/026158 |
| Data | 2005-03-24 |
| (30) | Numeris | Data | Šalis |
| 0321710 | 2003-09-16 | GB | |
| 0414440 | 2004-06-28 | GB |
| (72) |
BAENTELI, Rolf, CH
BERNHARD, Marie, Claude, FR
BUEHLMAYER, Peter, CH
COOKE, Nigel, Graham, CH
DUTHALER, Rudolf, CH
HINTERDING, Klaus, DE
THOMA, Gebhard, DE
VAN EIS, Maurice, FR
VON MATT, Anette, CH
WALLISER, Louis, FR
ZENKE, Gerhard, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Novartis Pharma GmbH, Brunner Strasse 59, 1230 Wien, AT |
| (54) | 2,4 DI(HETERO)-ARYLAMINO-PYRIMIDINE DERIVATIVES AS ZAP-70 AND/OR SYK INHIBITORS |
| 2,4 DI(HETERO)-ARYLAMINO-PYRIMIDINE DERIVATIVES AS ZAP-70 AND/OR SYK INHIBITORS |